<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> dysfunction and increased intramyocellular <z:chebi fb="23" ids="18059">lipid</z:chebi> (IMCL) content have both been implicated in the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, but the relative contributions of these two factors in the aetiology of <z:mp ids='MP_0002055'>diabetes</z:mp> are unknown </plain></SENT>
<SENT sid="1" pm="."><plain>As <z:hpo ids='HP_0001513'>obesity</z:hpo> is an independent determinant of IMCL content, we examined <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function and IMCL content in overweight type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients and BMI-matched normoglycaemic controls </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In 12 overweight type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients and nine controls with similar BMI (29.4 +/- 1 and 29.3 +/- 0.9 kg/m(2) respectively) in vivo <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function was determined by measuring phosphocreatine recovery half-time (PCr half-time) immediately after exercise, using <z:chebi fb="0" ids="37971">phosphorus-31</z:chebi> magnetic resonance spectroscopy </plain></SENT>
<SENT sid="3" pm="."><plain>IMCL content was determined by proton magnetic resonance spectroscopic imaging and insulin sensitivity was measured with a hyperinsulinaemic-euglycaemic clamp </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The PCr half-time was 45% longer in diabetic patients compared with controls (27.3 +/- 3.5 vs 18.7 +/- 0.9 s, p &lt; 0.05), whereas IMCL content was similar (1.37 +/- 0.30 vs 1.25 +/- 0.22% of the water resonance), and insulin sensitivity was reduced in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients (26.0 +/- 2.2 vs 18.9 +/- 2.3 mumol min(-1) kg(-1), p &lt; 0.05 [<z:hpo ids='HP_0000001'>all</z:hpo> mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>]) </plain></SENT>
<SENT sid="5" pm="."><plain>PCr half-time correlated positively with fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (r (2) = 0.42, p &lt; 0.01) and HbA(1c) (r (2) = 0.48, p &lt; 0.05) in diabetic patients </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS/INTERPRETATION: The finding that in vivo <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function is decreased in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients compared with controls whereas IMCL content is similar suggests that low <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function is more strongly associated with <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> than a high IMCL content per se </plain></SENT>
<SENT sid="7" pm="."><plain>Whether low <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> function is a cause or consequence of the disease remains to be investigated </plain></SENT>
</text></document>